Budd-Chiari syndrome likely related to a slimming drug preparation.
暂无分享,去创建一个
Y. Horsmans | J. Coche | A. Geubel | Y. Greer
[1] B. Winkelmann,et al. Mutation in coagulation factor V associated with resistance to activated protein C in patients with coronary artery disease , 1995, The Lancet.
[2] D. Valla,et al. Budd-Chiari syndrome and factor V Leiden mutation , 1995, The Lancet.
[3] M. Guillaume,et al. Veinotonic effect, vascular protection, antiinflammatory and free radical scavenging properties of horse chestnut extract. , 1994, Arzneimittel-Forschung.
[4] J. Piette,et al. Antiphospholipid syndrome as the second cause of non-tumorous Budd-Chiari syndrome. , 1994, Journal of hepatology.
[5] D. Valla,et al. Risk of hepatic vein thrombosis in relation to recent use of oral contraceptives. A case-control study. , 1986, Gastroenterology.
[6] D. Valla,et al. Primary myeloproliferative disorder and hepatic vein thrombosis. A prospective study of erythroid colony formation in vitro in 20 patients with Budd-Chiari syndrome. , 1985, Annals of internal medicine.
[7] R. Knodell,et al. Budd-Chiari syndrome in a patient with the lupus anticoagulant , 1984 .
[8] J. Cameron,et al. Budd‐Chiari Syndrome: Etiology, Diagnosis and Management , 1982, Medicine.
[9] J. Boyer,et al. Hepatic injury from chronic hypervitaminosis a resulting in portal hypertension and ascites. , 1974, The New England journal of medicine.
[10] L. Goodman,et al. THE PHARMACOLOGICAL BASIS OF THERAPEUTICS , 1966 .